A Long-term Treatment With B-VEC for Dystrophic Epidermolysis Bullosa
Trial details
- Registry ID
- NCT04917874
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Long-term Treatment With B-VEC for Dystrophic Epidermolysis BullosaNCT04917874 | KRYS | Phase 3 | Completed | 2023-07-31Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |